Epidemiological and humoral characteristics of children with comorbidity of COVID-19 and diabetes mellitus
Keywords:
Diabetes mellitus, hyperglycemia, diabetic ketoacidosis, COVID-19.Abstract
Introduction: The COVID-19 pandemic posed a challenge for children with comorbidities such as diabetes mellitus, a condition characterized by problems in glucose control due to a lack of insulin or resistance to it.
Objective: To describe the epidemiological and humoral characteristics of children with comorbidity of COVID-19 and diabetes mellitus.
Method: For this research, a systematic review of articles related to children with comorbidity of COVID-19 and diabetes mellitus was conducted using the PRISMA methodology. This follows a structured methodology that includes an exhaustive search for data in databases such as PubMed, SciELO, Scopus, Redalic, and Google Scholar, using specific descriptors in publications covering the last five years. The selection criteria include clinical and observational studies reporting hyperglycemia in patients with COVID-19, and those without specific data on diabetes and COVID-19 are excluded.
Development: The studied cases presented alterations such as a hyperglycemic state. It was demonstrated that SARS-CoV-2 can cause severe metabolic imbalances and even promote the emergence of new diabetes. It highlights the relevance of metabolic monitoring and early management of hyperglycemia in children with COVID-19 and diabetes to prevent problems and reduce the mortality rate. Conclusions: The interrelation between diabetes and COVID-19 underscores the need for a multifaceted and personalized approach in the treatment of these patients; careful management of hyperglycemia, control of comorbidities, and the implementation of comprehensive support strategies are essential to improve clinical outcomes and reduce mortality.Downloads
References
Lima Martínez MM, Carrera Boada C, Madera Silva MD, Marín W, Contreras M. COVID -19 and diabetes: A bidirectional relationship. Clin Investig Arterioscler. 2021 [citado 02/07/2025];33(3):151-157. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7598432/
Heald AH, Williams R, Jenkins DA, Stewart S, Bakerly ND, Mccay K, et al. The prevalence of long COVID in people with diabetes mellitus–evidence from a UK cohort. EClinicalMedicine. 2024 [citado 06/08/2025];71:102607. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC11133790/
Zhou W, Ye S, Wang W, Li S, Hu Q. Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia. J Diabetes Res. 2020[citado 03/07/2025];2020:3918723. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7545437/
Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020 [citado 06/08/2024];162:108142. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7144611/
Davis HE, McCorkell L, Moore Vogel J, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023 [citado 06/08/2024];21(3):133-146. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC9839201/
McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2021 [citado 09/06/2025];9(2):82-93. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7832778/
Zangrilloa A, Landonia G, Montib G, Yavorovskiyc AG, Baiardo Redaelli M. Dexametasona en COVID-19: ¿un medicamento para todos? Med Intens. 2022 [citado 06/08/2025];46(5):291-292. Disponible en: https://www.medintensiva.org/es-dexametasona-covid-19-un-medicamento-todos-articulo-S021056912100067X?covid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1
Kumar Singh A, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020 [citado 06/07/2025];14(4):303-310. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7195120
Orioli L, Hermans MP, Thissen JP, Maiter D, Vandeleene B, Yombi JC. COVID-19 in diabetic patients: Related risks and specifics of management. Ann Endocrinol (Paris). 2020 [citado 03/10/2025];81(2-3):101-109. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7217100/
Sharma P, Behl T, Sharma N, Singh S, Singh Grewal A, Albarrati A, et al. COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality. Biomed Pharmacother. 2022 [citado 06/07/2025];151:113089. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC9080053/
Muravlova OV, Shaienko ZO, Dvornyk IL, Sizova LM, Ilchenko VI, Purdenko TI, et al. Diabetes mellitus and COVID-19: living with double risk. Mìžnarodnij endokrinologìčnij žurnal. 2023 [citado 02/02/2026];19(6):448-454. Disponible en: https://iej-journal.com/index.php/journal/article/view/1315/1975
Li R, Shen M, Yang Q, Fairley CK, Chai Z, McIntyre R, et al. Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19- Related Severity and Mortality: A Systematic Review and Meta-analysis. Diabetes Care. 2023 [citado 03/08/2025];46(4):890-897. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC10090902/
Lestari CSW, Hartanti MD, Asmaria T. Prevalence of Hypertension and Diabetes in Severe COVID-19: A Cross-Sectional Study from Single Center, Kabul.Infect Drug Resist. 2024 [citado 06/08/2025];17:2225-2226. Disponible en: https://doi.org/10.2147/IDR.S477018
Al-Azzam N, Al-Azzam S, Khassawneh B, Araydah M, Karasneh RA, Aldeyab MA. Factors contributing to poor COVID-19 outcomes in diabetic patients: Findings from a single-center cohort study. PLoS One. 2023 [citado 03/08/2025];18(8). Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC10470961/
Landstra CP, de Koning EJP. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Front Endocrinol (Lausanne). 2021 [citado 06/05/2025];12:649525. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC8247904/
Chun SY, Kim DW, Lee SA, Lee SJ, Chang JH, Choi YJ, et al. Does diabetes increase the risk of contracting COVID-19? A population-based study in Korea. Diabetes Metab J. 2020 [citado 06/05/2025];44(6):897-907. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7801768/
Hernández García F, Lazo Herrera LA, Pérez García ER, Casanovas Figueroa J. Consideraciones epidemiológicas y clínicas de la COVID-19 en pacientes con diabetes mellitus. Rev Cubana Salud Pública. 2024 [citado 06/08/2025];49(4). Disponible en: https://revsaludpublica.sld.cu/index.php/spu/article/view/3356
Díaz Castrillón FJ, Toro Montoya AI. SARS-CoV-2/COVID-19: el virus, la enfermedad y la pandemia. Med Laboratorio. 2020 [citado 06/05/2025];24(3):183-205. Disponible en: https://www.redalyc.org/articulo.oa?id=716479665002
Sandoval López X. Fomentando el diálogo y la reflexión científica. Alerta. 2024 [citado 18/10/2025];7(2):125-126. Disponible en: https://camjol.info/index.php/alerta/article/view/17860
Sánchez Vallejos KY, Córdova Sánchez L del P, Cabrera Riveros JL, Llerena Zegarra EG, Guerreros Benavides A. COVID-19 en pacientes con asma bronquial en Clínica Internacional 2020-2021. Serie de casos. Interciencia Méd. 2024 [citado 06/05/2025];14(1):56-66. Disponible en: https://intercienciamedica.com/index.php/intercienciamedica/article/view/196
López V, Vázquez T, Alonso-Titos J, Cabello M, Alonso A, Beneyto I, et al. Recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (Covid-19) en pacientes con trasplante renal. Nefrología. 2020 [citado 06/05/2025];40(3):213-270. Disponible en:https://www.revistanefrologia.com/es-recomendaciones-el-manejo-pandemia-por-articuloS0211699520300370
Hernández Teixidó C. «Hola, Pedro»: la covid-19 y su relación con la hiperglucemia. Diabetes Práctica. 2020 [citado 06/02/2025];11(02):41-76. Disponible en: https://www.diabetespractica.com/files/1591870994.05_hernandez_dp-11-2.pdf
Díaz Castrillón FJ, Toro Montoya AI. Artículo de revisión SARS-CoV-2/COVID-19: el virus, la enfermedad y la pandemia. Medicina Laboratorio. 2020[citado 05/02/2025];24(3).Disponible en: https://docs.bvsalud.org/biblioref/2020/05/1096519/covid-19.pdf
Dillon JF, Miller MH. Gamma glutamyl transferase ‘To be or not to be’ a liver function test? Ann Clin Biochem.2016[citado 09/10/2025];53(6):629-631.Disponible en: https://journals.sagepub.com/doi/10.1177/0004563216659887
Torres Herrera A, Guerra González M, Vera González M. La Diabetes Mellitus tipo 1: una comorbilidad mortal para niños con Covid-19. UNIMED. 2022 [citado 03/08/2025];4(1). Disponible en: https://revunimed.sld.cu/index.php/revestud/article/view/145
Abad H, Acosta J, Acosta W, Ayala A, Chávez R, Carrillo D. Recomendaciones sobre el manejo de la diabetes mellitus durante la pandemia de covid-19.2Ecuador: El gobierno de todos;2020 [citado 09/10/2025]. Disponible en:
https://www.salud.gob.ec/wp-content/uploads/2020/07/RECOMENDACIONES-DIABETES-Y-COVID19.pdf
Franco VD, Morales Chorro L, Baltrons Orellana R, Rodríguez Salmerón CR, Santos Urbina O, López de Blanco C. Mortalidad por COVID-19 asociada a comorbilidades en pacientes del Instituto Salvadoreño del Seguro Social. Alerta. 2021 [citado 06/07/2025];4(2):28-37. Disponible en: https://alerta.salud.gob.sv/wp-content/uploads/2021/06/REVISTA-ALERTA-VOL-4-N2-NUMERO-ESPECIAL-COMPLETO-1-de-junio-de-2021.pdf
DiMeglio LA, Albanese-O’neill A, Muñoz CE, Maahs DM. COVID-19 and Children with Diabetes-Updates, Unknowns, and Next Steps: First, Do No Extrapolation. Diabetes Care. 2020 [citado 06/09/2025];43(11):2631-2634. Disponible en: https://diabetesjournals.org/care/article/43/11/2631/35794/COVID-19-and-Children-With-Diabetes-Updates
Cardenas Velasco GV, Muñoz N. Manifestaciones clínicas y diagnóstico de la enfermedad por Coronavirus 2019 en el paciente pediátrico. Ecuador J Med. 2022 [citado 06/10/2025];2(Num.Esp). Disponible en: https://revistafecim.org/index.php/tejom/article/view/101
Bellido V, Pérez A. Consequences of COVID-19 on people with diabetes. Endocrinol Diabetes Nutr. 2020 [citado 06/07/2025];67(6):355-356. Disponible en: https://www.elsevier.es/en-revista-endocrinologia-diabetes-nutricion-english-ed--413-articulo-consequences-covid-19-on-people-with-S2530018020300895
Leyva Montero MA, Teruel Ginés R, Bermúdez Garcell AJ. Infección por el SARS CoV-2 en pacientes diabéticos. Rev Cubana Endocrinol. 2022 [citado 06/08/2025];33(3). Disponible en: https://revendocrinologia.sld.cu/index.php/endocrinologia/article/view/359/0
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Jennifer Solange Narváez Andrade, Mateo Nicolás Oña Ortega, Ángela Micaela Ballesteros Chasipanta, María Ilusión Solís Sánchez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ACCESS AND DISTRIBUTION POLICY
All published articles are open access contributions, which are distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is properly cited.
